Miller Industries, Inc. (NYSE:MLR ) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Company Participants Michael Gaudreau - FTI Consulting William Miller - President and Chief Executive Officer Deborah Whitmire - Executive Vice President and Chief Financial Officer Conference Call Participants Michael Shlisky - D.A. Davidson Operator Good day, ladies and gentlemen, and welcome to the M...
CHATTANOOGA, Tenn. , May 7, 2025 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company") today announced financial results for the first quarter ended March 31, 2025.
CHATTANOOGA, Tenn. , April 30, 2025 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) intends to release its results for the First Quarter ended March 31, 2025, on Wednesday, May 7, 2025, after market close.
Q4 2024, Miller Industries reported disappointing results, including lower revenue and earnings, leading to a 15% stock drop and a 30% YTD decline. Net income grew 9% YoY in 2024, but profitability is expected to decrease in 2025, with EPS guidance revised down from $6 to $3 per share. Miller's growth is driven by an increasing number of vehicles on the road, more breakdowns, and rising car cra...
Miller Industries, Inc. (NYSE:MLR ) Q4 2024 Earnings Conference Call March 6, 2025 10:00 AM ET Company Participants Mike Gaudreau - FTI Consulting Will Miller - President and Chief Executive Officer Deborah Whitmire - Executive Vice President and Chief Financial Officer Conference Call Participants Linda Umwali - D.A. Davidson Operator Good day, ladies and gentlemen, and welcome to the Miller I...
CHATTANOOGA, Tenn. , March 5, 2025 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2024.
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--A groundbreaking Nature Cell Science article highlights how Membrane Lipid Replacement (MLR) using Nutritional Therapeutics' NTFactor® Lipids repairs mitochondrial damage, restores energy, and combats aging-related symptoms (https://doi.org/10.61474/ncs.2024.00038) This discovery builds on the lifetime work of Prof. Emeritus Garth Nicolson, PhD, MD (H)...
Despite Miller Industries' strong trailing growth, high inventory levels and tough comparables signal potential challenges ahead. MLR stock's MACD indicator suggests a potential sell signal unless Q4 results impress investors. Miller's high retention ratio limits its scope for sustained above-average growth, raising concerns about long-term value creation.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.